Indeed, some recent studies investigated circulating levels of CK-18 fragments as novel biomarkers for the presence of NASH in patients with NAFLD, and suggested the potential usefulness of this test in clinical practice. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.